Whether you are running an early Phase, a complete Phase 3 program or a bioequivalence clinical endpoint study, Symbio staff has specialized expertise, particularly with topical products.
The range of trial experience covers Dermatology, Inflammatory Disease, Aesthetics, Rare Disease, Medical Device, Gastroenterology, Oncology, and Ophthalmology.